Skip to content
  • Clinical Studies
  • Schedule M
  • Stability Studies
  • Pharma GMP
  • Pharma Tips
  • Pharma Books
  • Pharma Validation
  • Pharma Regulatory

SOP Guide for Pharma

The Ultimate Resource for Pharmaceutical SOPs and Best Practices

  • Home
  • SOP Guidelines
    • SOP Development
    • SOP Training
    • SOP Compliance Monitoring
    • SOP Revision Processes
    • Pharmaceutical SOP templates
    • GMP documentation SOP
    • Data integrity SOP pharma
    • Manufacturing SOP pharmaceutical
    • FDA SOP guidance
    • eQMS SOP workflows
  • Job Safety Analysis (JSA)
    • Oral Dosage Forms (Tablets & Capsules)
    • Oral Liquid Dosage Forms (Syrups, Elixirs, Suspensions, Emulsions)
    • Powder and Granule Dosage Forms
    • Topical Dosage Forms (Creams, Ointments, Gels, Lotions, Pastes)
    • Transdermal Dosage Forms (Patches)
  • Standard Test Procedures (STP)
  • GMP Audit Findings
    • Non-Compliance
      • SOP Absence
      • Revision Control
      • Non-Adherence
      • Poor Writing
      • Training Failure
      • Data Integrity Gaps
      • Mismatch Between SOPs and Practice
      • Critical Operations
      • Regulatory Change
      • Emergency Changes
      • Third-Party SOPs
      • Inspection Readiness
      • Deviation Handling
      • CAPA Integration
      • Validation Alignment
      • System Integration
      • Uncontrolled Distribution
      • SOP Implementation Gaps
      • SOP Alignment with Validation
      • Change Control Linkage
  • Toggle search form

GMP Audit Findings

Temporary SOP Changes Without Change Control: A Hidden Compliance Gap

Posted on By

Temporary SOP Changes Without Change Control: A Hidden Compliance Gap Unapproved Temporary SOP Changes: A Risky Shortcut in GMP Environments Introduction to the Audit Finding 1. Unrecorded Emergency Changes Violate GMP Temporary alterations to SOPs during emergencies must be documented under formal change control. Failure to do so constitutes a serious compliance gap. 2. Common…

Read More “Temporary SOP Changes Without Change Control: A Hidden Compliance Gap” »

Emergency Changes, GMP Audit Findings

Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events

Posted on By

Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events GMP Risks of Verbal Instructions Without SOP Addendum During Critical Events Introduction to the Audit Finding 1. Verbal Orders Bypass SOP Controls Issuing verbal instructions during critical operations without SOP addendums undermines written procedural control — a core GMP principle. 2. Common in Emergency or…

Read More “Verbal Instructions Without SOP Addendum: Regulatory Risk in Critical Events” »

Emergency Changes, GMP Audit Findings

Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness

Posted on By

Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness Overlooking SOP Revisions After Emergency Measures: A GMP Oversight Introduction to the Audit Finding 1. Emergency Measures Should Not Be Permanent Emergency actions in GMP operations are intended to be short-term responses — not lasting procedures unless properly documented and approved. 2. Risk of…

Read More “Failure to Update SOPs After Emergency Measures: A Persistent GMP Weakness” »

Emergency Changes, GMP Audit Findings

Lack of Training Following Temporary SOP Adjustments: A Compliance Gap

Posted on By

Lack of Training Following Temporary SOP Adjustments: A Compliance Gap Training Deficiencies After Temporary SOP Adjustments: A Hidden GMP Risk Introduction to the Audit Finding 1. Untrained Staff Apply Uncontrolled Methods After a temporary change in SOP, if staff are not promptly trained, they continue using old or inconsistent methods — a GMP risk. 2….

Read More “Lack of Training Following Temporary SOP Adjustments: A Compliance Gap” »

Emergency Changes, GMP Audit Findings

Conflicting Procedures During Line Stoppage: A GMP Compliance Breakdown

Posted on By

Conflicting Procedures During Line Stoppage: A GMP Compliance Breakdown Resolving SOP Conflicts During Line Stoppages to Ensure GMP Compliance Introduction to the Audit Finding 1. Conflicting Instructions During Line Halt Line stoppages triggered by machine failure, contamination, or power issues often activate conflicting SOPs, leading to confusion among operators and supervisors. 2. Risk to Product…

Read More “Conflicting Procedures During Line Stoppage: A GMP Compliance Breakdown” »

Emergency Changes, GMP Audit Findings

Ensuring Integration of Third-Party SOPs into Internal Quality Systems

Posted on By

Ensuring Integration of Third-Party SOPs into Internal Quality Systems Bridging the SOP Gap Between Contract Manufacturers and Internal GMP Systems Introduction to the Audit Finding 1. The Outsourcing Challenge Many pharmaceutical companies outsource manufacturing to contract facilities. However, failure to integrate their SOPs into the internal Quality Management System (QMS) can lead to serious GMP…

Read More “Ensuring Integration of Third-Party SOPs into Internal Quality Systems” »

GMP Audit Findings, Third-Party SOPs

Addressing Oversight Failures in Third-Party SOP Compliance

Posted on By

Addressing Oversight Failures in Third-Party SOP Compliance Improving Oversight of Third-Party SOP Compliance in GMP Operations Introduction to the Audit Finding 1. What the Issue Involves This audit finding pertains to inadequate internal oversight of Standard Operating Procedures (SOPs) at third-party sites such as contract manufacturers (CMOs), laboratories, or packagers. 2. GMP Accountability Still Rests…

Read More “Addressing Oversight Failures in Third-Party SOP Compliance” »

GMP Audit Findings, Third-Party SOPs

Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates

Posted on By

Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates Establishing Robust Procedures for Vendor SOP Updates Review in GMP Systems Introduction to the Audit Finding 1. The Gap Explained This audit finding highlights the absence of a documented process for reviewing updated SOPs received from vendors or third-party service providers. 2. GMP Relevance In…

Read More “Ensuring GMP Through Formal Review Procedures for Vendor SOP Updates” »

GMP Audit Findings, Third-Party SOPs

Resolving SOP Discrepancies Between Sponsors and Contract Labs in Analytical Testing

Posted on By

Resolving SOP Discrepancies Between Sponsors and Contract Labs in Analytical Testing Managing Analytical Testing SOP Discrepancies Between Sponsor and Contract Laboratories Introduction to the Audit Finding 1. What the Finding Means This issue arises when the sponsor’s internal SOPs for analytical testing differ from those used by the contract lab performing critical analyses on their…

Read More “Resolving SOP Discrepancies Between Sponsors and Contract Labs in Analytical Testing” »

GMP Audit Findings, Third-Party SOPs

Ensuring SOP Alignment with Outsourced Logistics Providers for GMP Compliance

Posted on By

Ensuring SOP Alignment with Outsourced Logistics Providers for GMP Compliance Bridging SOP Gaps with Outsourced Logistic Partners in Pharma Distribution Introduction to the Audit Finding 1. What Was Observed During GMP inspections, it is frequently noted that pharmaceutical companies fail to share critical SOPs with their third-party logistics (3PL) providers. 2. Why It Matters When…

Read More “Ensuring SOP Alignment with Outsourced Logistics Providers for GMP Compliance” »

GMP Audit Findings, Third-Party SOPs

Posts pagination

Previous 1 … 6 7 8 … 12 Next

Standard Operating Procedures V 1.0

  • Aerosols
  • Analytical Method Development
  • Bioequivalence Bioavailability Study
  • Capsule Formulation
  • Clinical Studies
  • Creams
  • Data Integrity
  • Dental Dosage Forms
  • Drug Discovery
  • Environment, Health and Safety
  • Formulation Development
  • Gels
  • Good Distribution Practice
  • Good Warehousing Practices
  • In-Process Control
  • Injectables
  • Liquid Orals
  • Liposome and Emulsion Formulations
  • Lotions
  • Lyophilized Products
  • Maintenance Dept.
  • Medical Devices
  • Metered-Dose Inhaler
  • Microbiology Testing
  • Nanoparticle Formulation
  • Nasal Spray Formulations
  • Nebulizers
  • Ocular (Eye) Dosage Forms
  • Ointments
  • Otic (Ear) Dosage Forms
  • Pharmacovigilance
  • Powder & Granules
  • Purchase Departments
  • Quality Assurance
  • Quality Control
  • Raw Material Stores
  • Regulatory Affairs
  • Tablet Manufacturing
  • Rectal Dosage Forms
  • Transdermal Patches
  • Vaginal Dosage Forms
  • Validations and Qualifications

Read SOPs in your Language:

 - 
Bengali
 - 
bn
English
 - 
en
Gujarati
 - 
gu
Hindi
 - 
hi
Malayalam
 - 
ml
Marathi
 - 
mr
Punjabi
 - 
pa
Tamil
 - 
ta
Telugu
 - 
te

NEW! Revised SOPs – V 2.0

  • Aerosols V 2.0
  • Analytical Method Development V 2.0
  • API Manufacturing V 2.0
  • BA-BE Studies V 2.0
  • Biosimilars V 2.0
  • Capsules V 2.0
  • Creams V 2.0
  • Elixers V 2.0
  • Gels V 2.0
  • Injectables V 2.0
  • Ointments V 2.0
  • Raw Material Warehouse V 2.0
  • Tablet Manufacturing V2.0

New Publication: A must for All.

Copyright © 2025 SOP Guide for Pharma.

Powered by PressBook WordPress theme